The prevalence of germline BRCA1 and BRCA2 P/LP variants was 0.24% and 0.79%, respectively, according to a large survey encompassing 6220 Chinese patients with advanced NSCLC.11 Here, BRCA2 is linked to non-small cell lung carcinoma.